38575503|t|Regulating Lars2 in mitochondria: A potential Alzheimer's therapy by inhibiting tau phosphorylation.
38575503|a|Driven by the scarcity of effective treatment options in clinical settings, the present study aimed to identify a new potential target for Alzheimer's disease (AD) treatment. We focused on Lars2, an enzyme synthesizing mitochondrial leucyl-tRNA, and its role in maintaining mitochondrial function. Bioinformatics analysis of human brain transcriptome data revealed downregulation of Lars2 in AD patients compared to healthy controls. During in vitro experiments, the knockdown of Lars2 in mouse neuroblastoma cells (neuro-2a cells) and primary cortical neurons led to morphological changes and decreased density in mouse hippocampal neurons. To explore the underlying mechanisms, we investigated how downregulated Lars2 expression could impede the phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT) pathway, thereby mitigating AKT's inhibitory effect on glycogen synthase kinase 3 beta (GSK3beta). This led to the activation of GSK3beta, causing excessive phosphorylation of Tau protein and subsequent neuronal degeneration. During in vivo experiments, knockout of lars2 in hippocampal neurons confirmed cognitive impairment through the Barnes maze test, the novel object recognition test, and nest-building experiments. Additionally, immunofluorescence assays indicated an increase in p-tau, atrophy in the hippocampal region, and a decrease in neurons following Lars2 knockout. Taken together, our findings indicate that Lars2 represents a promising therapeutic target for AD.
38575503	11	16	Lars2	Gene	23395
38575503	46	57	Alzheimer's	Disease	MESH:D000544
38575503	80	83	tau	Gene	4137
38575503	240	259	Alzheimer's disease	Disease	MESH:D000544
38575503	261	263	AD	Disease	MESH:D000544
38575503	290	295	Lars2	Gene	23395
38575503	426	431	human	Species	9606
38575503	484	489	Lars2	Gene	23395
38575503	493	495	AD	Disease	MESH:D000544
38575503	496	504	patients	Species	9606
38575503	581	586	Lars2	Gene	102436
38575503	590	595	mouse	Species	10090
38575503	596	609	neuroblastoma	Disease	MESH:D009447
38575503	617	625	neuro-2a	CellLine	CVCL:0470
38575503	716	721	mouse	Species	10090
38575503	815	820	Lars2	Gene	23395
38575503	897	901	PI3K	Gene	18708
38575503	902	905	AKT	Gene	11651
38575503	935	938	AKT	Gene	11651
38575503	962	993	glycogen synthase kinase 3 beta	Gene	56637
38575503	995	1003	GSK3beta	Gene	56637
38575503	1036	1044	GSK3beta	Gene	56637
38575503	1083	1086	Tau	Gene	4137
38575503	1110	1131	neuronal degeneration	Disease	MESH:D009410
38575503	1173	1178	lars2	Gene	102436
38575503	1212	1232	cognitive impairment	Disease	MESH:D003072
38575503	1396	1399	tau	Gene	4137
38575503	1401	1408	atrophy	Disease	MESH:D001284
38575503	1472	1477	Lars2	Gene	23395
38575503	1531	1536	Lars2	Gene	23395
38575503	1583	1585	AD	Disease	MESH:D000544
38575503	Association	4137	56637
38575503	Association	11651	18708
38575503	Positive_Correlation	23395	4137
38575503	Negative_Correlation	11651	56637
38575503	Association	MESH:D000544	4137
38575503	Association	18708	23395
38575503	Association	MESH:D001284	23395
38575503	Association	MESH:D003072	102436
38575503	Association	11651	23395
38575503	Association	MESH:D009410	4137
38575503	Association	23395	56637
38575503	Negative_Correlation	MESH:D000544	23395
38575503	Association	MESH:D009410	23395
38575503	Association	MESH:D009447	102436

